This inventor holds 1 USPTO granted patent. Top assignee: The University of Chicago. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Cathyrn R Nagler: Innovator in Microbiota Research
Introduction
Cathyrn R Nagler is a prominent inventor based in Chicago, IL, known for her significant contributions to the field of microbiota research. She has developed innovative methods aimed at inhibiting enteric infections, showcasing her dedication to advancing medical science.
Latest Patents
Nagler holds a patent titled "Inhibition of enteric infection through the modulation of microbiota." This patent outlines compositions and methods for preventing or decreasing susceptibility to enteric infections. Specifically, it involves administering bacteria of the class Clostridia to human and/or animal subjects, which has the potential to revolutionize approaches to gastrointestinal health.
Career Highlights
Cathyrn R Nagler is affiliated with the University of Chicago, where she conducts her research and contributes to the academic community. Her work has garnered attention for its innovative approach to understanding the role of microbiota in health and disease.
Collaborations
Nagler collaborates with esteemed colleagues, including Gabriel Nunez and Yun-Gi Kim, enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Cathyrn R Nagler's work exemplifies the intersection of innovation and health, particularly in the realm of microbiota and enteric infections. Her contributions are paving the way for new therapeutic strategies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile